Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06413888
Other study ID # H-43383
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 1, 2018
Est. completion date December 31, 2023

Study information

Verified date May 2024
Source Baylor College of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pancreaticoduodenectomy (PD) remains the gold-standard operation for peri-ampullary neoplasms. Traditionally, gastric decompression via nasogastric intubation has been employed postoperatively to prevent nausea, vomiting, aspiration pneumonia, anastomotic leakage and delayed gastric emptying. Recently, the implementation of ERAS protocol recommended against routine use of nasogastric tube following PD. however, limited data exists surrounding the identification of those patients needing NGT decompression in the immediate postoperative period. Therefore, we initiated a large prospective randomized controlled trial to evaluate the clinical outcomes of patients who retained the NGT post-PD versus those who had it removed at the end of the procedure. This study aims to assess the effectiveness of nasogastric decompression in PD recovery, with the primary endo point being the need for and impact of NGT in the postoperative recovery. The secondary endpoint will examined the re-insertion rate of NGT and identify factors that necessitate its use in the immediate postoperative period.


Recruitment information / eligibility

Status Completed
Enrollment 230
Est. completion date December 31, 2023
Est. primary completion date May 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All patients 18 years of age or older - Patients undergoing successful pancreaticoduodenectomy for benign or malignant neoplasm. Exclusion Criteria: - Patients who does not complete the procedure due to locally advanced or metastatic disease discovered during the procedure. - Patient who requires prolong postoperative intubation in the postoperative period.

Study Design


Intervention

Procedure:
pancreaticoduodenectomy
Surgical removal of the head of the pancreas, duodenum, extrahepatic bile duct, distal stomach, and proximal jejunum. Group A cohort will not have NGT placed in the postoperative period. Whereas, group B will have the NGT retained in the posoperative period

Locations

Country Name City State
United States Baylor college of medicine Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
Baylor College of Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary to assess whether nasogastric decompression following a whipple procedure will reduce the incidence and severity of postoperative complications Severity of post operative complications was graded according to the Clavien-Dindo classification system adopted for pancreaic surgery, which relies on the type of treatment used for each complication with scores range from 1-4, and any complication graded >2 considered a major complication. 30-days postoperatively
Secondary Examined the re-insertion rate of Nasogastric tube following pancreaticoduodenectomy Patient will be considered to undergo nasogastric decompression with nasogastric tube if he/she demonstrated clinical evidence of postoperative ileus and delayed gastric emptying as defined according to the consensus definition proposed by the international study group of pancreatic surgery (ISGPS), the severity of which was classified into 3 grades (A,B, and C) based on clinical course and postoperative management such as the need nausea and vomiting and inability to tolerate solid oral intake by the end of the first postoperative week. 30- days postoperatively
Secondary identify factors that necessitated its use in the immediate postoperative period To identify preoperative factors such as obesity with BMI 30 or more, Preoperative uncontrolled diabtes, older age (over 70), gender (male/female), histroy of gastric outlet obstruction, primary diagnosis (malignant disease vs benign). Intra-operative factor such such as the length of the procedure, blood loss, any concurrent procedure such as extensive lysis of adhesions, colon resection; and postoperative factors including postoperative blood counts, phosphorus and magnesium levels, blood sugar level, and postoperative complications. These factors will be assessed using logistic regression analysis to predict the necessity of nasogastric decompression in the postoperative period following the whipple procedure. 30 days postoperatively
See also
  Status Clinical Trial Phase
Terminated NCT03757455 - ERAS Protocol in Pancreaticoduodenectomy and Total Pancreatectomy N/A
Recruiting NCT04118881 - Ear Acupuncture Preventing Delayed Gastric Emptying. N/A
Recruiting NCT06038734 - Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.
Recruiting NCT06452966 - The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients N/A
Enrolling by invitation NCT02086461 - Pylorus Dysfunction After Esophagectomy and Gastric Tube Reconstruction. Effect of Pneumatic Pylorus Dilatation During Hospital Stay, Surgical Complications During in Hospital Stay N/A
Not yet recruiting NCT05314244 - Comparison Between Pylorus-resecting and Preserving Pancreaticoduodenectomy on Delayed Gastric Emptying and Nutrition N/A
Completed NCT02447237 - Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic Patients N/A
Recruiting NCT05518643 - Compliance With ERAS Protocol in Pancreatic Surgery, Stress Response and Outcomes
Completed NCT03734627 - Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery
Recruiting NCT04418739 - Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes Phase 2
Recruiting NCT02635399 - Impact of Additional DJ (Duodenojejunostomy)-Pexy on Reduction in Delayed Gastric Emptying Following Pylorus-preserving Pancreaticoduodenectomy: A Prospective, Randomized Controlled Trial N/A
Active, not recruiting NCT05657327 - Application and Optimization of the International Study Group of Pancreatic Surgery (ISGPS) Definition and Grading Criteria for Postoperative Complications of Pancreatic Surgery in Laparoscopic Pancreatic Surgery
Completed NCT02397577 - Reference Values for Gastric Emptying N/A
Recruiting NCT05674643 - Gastric Assessment of Pediatric Patients Undergoing Surgery
Completed NCT03525067 - Colonization of Bile Ducts and Postoperative Infectious Complications of Pancreaticoduodenectomies
Terminated NCT01481753 - Pancreaticoduodenectomy With or Without Braun Enteroenterostomy: Comparison of Postoperative Pancreatic Fistula and Delayed Gastric Emptying N/A
Completed NCT03984734 - Quality of Life and Nutritional Status After Two Surgical Techniques in Pancreatoduodenectomy N/A
Withdrawn NCT02745028 - Monosodium Glutamate on Gastric Emptying N/A
Completed NCT00845858 - Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis Phase 2
Recruiting NCT05709197 - The Effectiveness of Adding Braun Anastomosis to Standard Child Reconstruction After Pancreatoduodenectomy N/A